Add to this the possibility that the 1500 will tape out soon - perhaps with a Megachips client as the recipient? AIMO.The FED last week raised interest rates .25%, but there was some clear language from JP that its very possible that it might be the last.
Tech stocks have been the worst hit in this current enviroment, so should see better than average rebound if no further interest rate rises.
The Nasdaq had a ball tearer on Friday as did many tech stocks on what i believe was the wording from JP.
Its my opinion that BRN was helped by the JP wording , along with the upcoming BRN/ARM Tech Talk (collaboration) and just maybe the shorting activity might be feeling that the s/p is not going much lower. (just a feeling)
Also, we all saw how quickly the BRN s/p retaliated 2 weeks ago after being knocked down into the mid 30s.
ARM COLLABORATION
RENASAS TAPE-OUT
BRN .............................. the most exciting stock on the ASX
AKIDA BALLISTA
And perhaps Morse Micro IS the client. Have come across this this employee from Morse Micro who has recently published this paper. Sorry about the screen shot quality, not quite sure how to post LinkedIn links.Add to this the possibility that the 1500 will tape out soon - perhaps with a Megachips client as the recipient? AIMO.
And perhaps Morse Micro IS the client. Have come across this this employee from Morse Micro who has recently published this paper. Sorry about the screen shot quality, not quite sure how to post LinkedIn links.
View attachment 35925
View attachment 35926 View attachment 35929
The only link I know of is that Megachips is an investor in Morse Micro and is helping with the design of their chips.Has there been a link established with Morse Micro? From what I understand, they are not currently a partner on Brainchip's website. This paper, from what I understand, is just MM doing software simulations of chip-based SNNs utilising various different models on how the learning happens (no JAST mentioned).
Thanks TopCat,And perhaps Morse Micro IS the client. Have come across this this employee from Morse Micro who has recently published this paper. Sorry about the screen shot quality, not quite sure how to post LinkedIn links.
View attachment 35925
View attachment 35926 View attachment 35929
I think this recent partnership between Teksun (our buddies) and Vivoka might be worth keeping an eye on.
View attachment 35945
View attachment 35944![]()
Vivoka & Teksun partner to develop innovative solution – Vivoka
Vivoka and Teksun signed a partnership agreement to collaborate on innovative technology, products, and services.vivoka.com
Megachips invested $100million last year and may be that makes megachips a major holder in Morse micro. Even megachips is selling MM solutions.The only link I know of is that Megachips is an investor in Morse Micro and is helping with the design of their chips.
Edge Impulse, the industry-leading development toolkit for machine learning, is collaborating with Know Labs to accelerate Bio-RFID’s algorithm refinement, an essential step for interpreting its existing robust data set and ultimately supporting large-scale clinical trials. Edge Impulse has partnered with companies in similar stages of development across a variety of fields in health, health wearable technology, agriculture and infrastructure. “We’ve spent the last six months working alongside Know Labs’ software team to accelerate algorithm development for their non-invasive glucose monitor and are reminded each day how incredible it is to demonstrate algorithm performance in such novel data,” said Zach Shelby, co-founder and CEO of Edge Impulse.Scientific Validation
Know Labs is advancing the testing of Bio-RFID, progressing on the path to FDA submission for clearance as a medical-grade device. As we prioritize external validation of our technology and transparency in our progress, we are continuously adding to a growing body of evidence.
Technical Feasibility Clinical Study
May 5, 2023
A study titled, “Technical Feasibility of a Novel Sensor for Non-Invasive Blood Glucose Monitoring Compared to Dexcom G6®,” demonstrates that the Bio-RFID sensor can deliver stable, repeatable results in predicting blood glucose concentrations using the Dexcom G6® as a reference device. Results were presented at American Association of Clinical Endocrinology (AACE) 2023 Annual Meeting.
Poster
Abstract
Proof of Principle Study in Collaboration with Mayo Clinic
April 21, 2023
A study titled, “Detecting Unique Analyte-Specific Radio Frequency Spectral Responses in Liquid Solutions – Implications for Non-Invasive Physiologic Monitoring,” was conducted in collaboration with Mayo Clinic and demonstrates the accuracy of Know Labs’ non-invasive Bio-RFID technology in quantifying different analytes in vitro. Results were presented at the American Physiological Society 2023 Summit.
Poster
Abstract
Proof of Concept Clinical Study
February 28, 2023
This technical report titled, "Non-Invasive Blood Glucose Monitoring: A Validation of a Novel Sensor Compared to a Dexcom G6®," presents proof of concept for a new method to quantify blood glucose levels (BGL) in vivo non-invasively using RF methods by means of training a model to predict readings of the Dexcom G6®, as a proxy for BGL. The method uses a new type of sensing device that rapidly scans a wide band of RF frequencies. The report outlines data science techniques used to train a neural network model to make predictions, and includes metrics of model success and future directions of this work. Results were peer-reviewed by Know Labs Scientific advisory board.